This bill creates a new category of tax-exempt organizations focused on making drugs and medical devices more affordable. Right now, nonprofits can get tax-exempt status, but this bill specifically allows organizations that manufacture or distribute drugs and medical devices to qualify for that status if they meet certain requirements.

To get this special designation, an organization must prove that its main goal is making drugs or medical devices affordable, it's based and operates in the United States, and it's not controlled by for-profit companies. The organization also has to follow strict rules about who sits on its board—basically, board members and executives can't have ties to for-profit drug or device companies, with very limited exceptions. Additionally, if the government asks, the organization must agree to give priority access to purchase at least 25 percent of their production for the national stockpile during emergencies, at the same price they offer other customers.

The bill focuses on drugs and devices that address real needs—things that are in short supply, could significantly reduce costs for patients, fill gaps in available treatments, or address public health emergencies. Organizations can request this designation by showing they can make or distribute qualifying products and agreeing to the stockpile priority arrangement. The bill also includes rules about what funding these organizations can accept, limiting outside funding to small amounts, government grants, or money directly tied to purchasing their products. This essentially gives nonprofits a clearer path to operate in the drug and medical device space while maintaining their tax-exempt status, as long as they prioritize affordability and public health over profits.